1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013. http://www.who.int/hiv/pub/guidelines/arv2013 . Accessed 26 Jan 2016.
2. Ministry of Health, Republic of Uganda. Addendum to the national antiretroviral treatment guidelines. December 2013. http://preventcrypto.org/wp-content/uploads/2012/07/Uganda-National-ART-Guidelines_2014.pdf . Accessed 15 Jan 2015.
3. Ministry of Health, Republic of Kenya, (NASCOP). NAaSCP. Guidelines on use of antiretroviral drugs for treating and preventing HIV infection: a rapid advice, 2014. http://guidelines.health.go.ke:8000/media/Rapid_Advice_Booklet_2014_July_V5.pdf . Accessed 17 Feb 2016.
4. Ministry of Health and Social Welfare, The United Republic of Tanzania, Programme. NAC. The United Republic of Tanzania. National guidelines for the management of HIV and AIDS. 5th edn, May, 2015. http://www.nacp.go.tz/site/publications/care-and-treatment/ NationalGuidelineforManagementHIV.pdf. Accessed 15 Feb 2016.
5. Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis. 2011;57:773–80.